Tag: GSS

Genetic Signatures coronavirus test kit diagnostic UK EU Europe United Kingdom ASX GSS

Genetic Signatures applies to market coronavirus test kit throughout UK and EU

Molecular diagnostics company Genetic Signatures (ASX: GSS) has submitted a European CE in vitro diagnostics registration application for its new 3base EasyScreen coronavirus detection kit. The kit...
Genetic Signatures ASX GSS pathogen detection kit Europe EasyScreen

Genetic Signatures receives green light to market pathogen detection kit in Europe

Molecular diagnostics company Genetic Signatures (ASX: GSS) has received CE-IVD registration, paving the way for the sale of its “EasyScreen” Respiratory Pathogen Detection Kit in Europe. The detec...
Genetic Signatures ASX GSS EasyScreen respiratory technology pathogen detection kit

Genetic Signatures secures ‘major’ sales contract for EasyScreen respiratory technology

Molecular diagnostics company Genetic Signatures (ASX: GSS) has announced a major new contract with a large Australian pathology service provider and release of two new products. Genetic Signatures...
Genetic Signatures ASX GSS TGA superbugs detection kit antibiotic resistance

Genetic Signatures receives approval to market superbug detection kits in Australia

Molecular diagnostics company Genetic Signatures (ASX: GSS) has received Therapeutic Goods Administration (TGA) registration, thereby allowing the sale of its novel “Extended Spectrum Beta-Lactamase a...

RECENT POSTS

STOCK SUMMARY

FOLLOW US

HOT TOPICS

TRENDING POSTS